SCHEMBL8673190

SCHEMBL8673190

Cc1c(O)cccc1C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)OCc1cccnc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 6/20 0.54
CTRB1 P17538 2/20 0.41
CTSL P07711 2/20 0.41
CTSB P07858 2/20 0.41
GPR132 Q9UNW8 3/20 0.41
HDAC3 O15379 1/20 0.41
HDAC4 P56524 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC7 Q8WUI4 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC10 Q969S8 1/20 0.41
HDAC11 Q96DB2 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
HDAC9 Q9UKV0 1/20 0.41
HDAC5 Q9UQL6 1/20 0.41
CMKLR2 P46091 1/20 0.41
CMKLR1 Q99788 1/20 0.41
CCR1 P32246 1/20 0.40
EPHX1 P07099 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7357618 0.86 CYP3A4 (0.64) CYP3A4CTRB1CTSLCTSBGPR132
SCHEMBL7303011 0.85 CYP3A4 (0.63) CYP3A4CTRB1CTSLCTSBMEN1
SCHEMBL7305488 0.85 CYP3A4 (0.63) CYP3A4CTRB1CTSLCTSBMEN1
SCHEMBL7569915 0.85 CYP3A4 (0.63) CYP3A4CTRB1CTSLCTSBMEN1
SCHEMBL8668860 0.82 ATM (0.49) CTSLCTSB
SCHEMBL7305834 0.81 CYP3A4 (0.59) CYP3A4CTSLCTSB
SCHEMBL7311171 0.81 CYP3A4 (0.59) CYP3A4CTSLCTSB
SCHEMBL7565435 0.81 CYP3A4 (0.59) CYP3A4CTSLCTSB
SCHEMBL7312307 0.81 CYP3A4 (0.58) CYP3A4CTSLCTSBMEN1SLC22A2
SCHEMBL7344979 0.80 CYP3A4 (0.57) CYP3A4CTRB1CTSLCTSBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5763464-A TREATING HUMAN IMMUNODEFICIENCY VIRUS INFECTIONS THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1998-06-09 US disclosed
WO-1997019061-A1 RETROVIRAL AGENTS CONTAINING ANTHRANILAMIDE, SUBSTITUTED BENZAMIDE AND OTHER SUBUNITS, AND METHODS OF USING SAME THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1997-05-29 WO disclosed